Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles.

about

Localized delivery of mechano-growth factor E-domain peptide via polymeric microstructures improves cardiac function following myocardial infarction Biomimetic strategies for targeted nanoparticle delivery.

P2860

Q35083679-DBEE2466-3794-474E-91C3-CDB2B721385E Q55209384-DDFC2A61-C3BB-4B05-8E81-729AE0ACE50F

P2860

Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles.

Item

http://www.wikidata.org/entity/Q40335819

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Intranasal, siRNA Delivery to ...... ylated Chitosan Nanoparticles.

@en

type

Item

label

Intranasal, siRNA Delivery to ...... ylated Chitosan Nanoparticles.

@en

prefLabel

Intranasal, siRNA Delivery to ...... ylated Chitosan Nanoparticles.

@en

P1476

Intranasal, siRNA Delivery to ...... Gylated Chitosan Nanoparticles

@en

P2093

Meenakshi Malhotra

http://www.w3.org/2001/XMLSchema#string

Shyamali Saha

http://www.w3.org/2001/XMLSchema#string

P2860

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

In vivo protein transduction: delivery of a biologically active protein into the mouse

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine.

Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.

Development of neuropeptide drugs that cross the blood-brain barrier.

Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration

Blood-brain barrier drug targeting: the future of brain drug development.

Efficient and targeted delivery of siRNA in vivo.

P304

812387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/812387

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Catherine Tomaro-duchesneau

S Prakash

P577

2013-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256870846

http://www.w3.org/2001/XMLSchema#string

P698

26555995

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

P932

4590831

http://www.w3.org/2001/XMLSchema#string

Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles.

about

P2860

P2860

Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932